Home
>
National Drug Code (NDC)
>
Chlorzoxazone
Chlorzoxazone - 0591-2520-01 - (Chlorzoxazone)
Drug Information of Chlorzoxazone
| Product NDC: | 0591-2520 |
| Proprietary Name: | Chlorzoxazone |
| Non Proprietary Name: | Chlorzoxazone |
| Active Ingredient(s): | 500 mg/1 & nbsp; Chlorzoxazone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Chlorzoxazone
| Product NDC: | 0591-2520 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089859 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110822 |
Package Information of Chlorzoxazone
| Package NDC: | 0591-2520-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0591-2520-01) |
NDC Information of Chlorzoxazone
| NDC Code | 0591-2520-01 |
| Proprietary Name | Chlorzoxazone |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0591-2520-01) |
| Product NDC | 0591-2520 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chlorzoxazone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110822 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | CHLORZOXAZONE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
